Corcept Therapeutics Incorporated · NASDAQ:CORT
Wilson James N sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Jul 15, 2026 · Filed Jul 17, 2026
On Jul 15, 2026, Wilson James N (Director) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$88.30 for US$883K under a trading plan, leaving 1,084,543 shares. Filed Jul 17, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$88.30 average (US$86.78 to US$89.49)
- Value
- US$883K
- Holding after
- 1,084,543 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | Sale | 1,079 | US$86.78 | 1,093,464 | Indirect |
| Jul 15, 2026 | Common Stock | Sale | 3,969 | US$87.74 | 1,089,495 | Indirect |
| Jul 15, 2026 | Common Stock | Sale | 2,974 | US$88.81 | 1,086,521 | Indirect |
| Jul 15, 2026 | Common Stock | Sale | 1,978 | US$89.49 | 1,084,543 | Indirect |
Source
Related
- Corcept Therapeutics Incorporated
- Wilson James N
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Wilson James N · Sep 16, 2026
- Form 4 · Wilson James N · Aug 18, 2026
- Form 4 · Wilson James N · Jun 18, 2026
- Form 4 · Wilson James N · May 29, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026